Readoutin 45d
ModernaTX, Inc. — mRNA-1018-H5
Phase 3 primary completion: A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults.
- Date
- Jan 2027
- Type
- Readout
- Indication
- Influenza
Readoutin 45d
Phase 3 primary completion: A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.